Sabby Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-176
Closed -$556K 58
2025
Q1
$556K Buy
+176
New +$146K 1.64% 15
2017
Q1
Sell
-23,675
Closed -$174M 286
2016
Q4
$174M Sell
23,675
-5,672
-19% -$422K 10.13% 1
2016
Q3
$236M Sell
29,347
-774
-3% -$62K 8.82% 2
2016
Q2
$237M Buy
30,121
+1,159
+4% +$87.3K 12.38% 1
2016
Q1
$209M Buy
28,962
+5,168
+22% +$391K 10.43% 1
2015
Q4
$200M Buy
23,794
+1,939
+9% +$161K 11.03% 1
2015
Q3
$183M Sell
21,855
-4,816
-18% -$407K 7.54% 3
2015
Q2
$223M Buy
26,671
+16,710
+168% +$1.27M 8.12% 2
2015
Q1
$72.4M Buy
9,961
+3,556
+56% +$253K 3.01% 7
2014
Q4
$44.2K Buy
6,405
+2,046
+47% +$138K 1.4% 14
2014
Q3
$28.3K Buy
+4,359
New +$276K 1.09% 17
2014
Q2
Sell
-1,719
Closed -$10.1M 278
2014
Q1
$10.1M Buy
+1,719
New +$95.9K 0.57% 43
2013
Q3
Sell
-10,238
Closed -$50.3M 210
2013
Q2
$50.3M Buy
+10,238
New +$557K 3.36% 5

Other funds holding LLY

Sabby Management's LLY Position: Q2 2025 in Review

Sabby Management sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 3,420 shares — an estimated $2.82M sold.

Sabby Management first reported a position in LLY in Q2 2013 and held it in 5 quarters. The position peaked at $15.7M in Q4 2016. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Sabby Management reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Sabby Management sold 3,420 Eli Lilly shares in Q2 2025, an estimated $2.82M.
  • Sabby Management first reported a position in Eli Lilly in Q2 2013 and held it in 5 quarters.
  • Sabby Management's Eli Lilly position peaked at $15.7M in Q4 2016.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Sabby Management's 13F filing for Q2 2025, filed 14 Aug 2025.